Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
JP Stock MarketDetailed Quotes
8070 Tokyo Sangyo
- 711
- -7-0.97%
20min DelayMarket Closed Jan 9 15:30 JST
20.39BMarket Cap-11.66P/E (Static)
717High711Low38.40KVolume717Open718Pre Close27.36MTurnover86452wk High0.22%Turnover Ratio28.68MShares60052wk Low79.01EPS TTM12.41BFloat Cap929Historical HighLossP/E (Static)17.46MShs Float202Historical Low-60.96EPS LYR0.84%Amplitude36.00Dividend TTM0.93P/B100Lot Size5.06%Div YieldTTM
Tokyo Sangyo Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.64%65.03B | 13.42%19.21B | -1.09%14.45B | 17.49B | 13.88B | 65.45B | 16.94B | 14.6B |
| Cost of revenue | -0.59%58B | -1.08%16.49B | 11.76%14.04B | 15.83B | 11.64B | 58.34B | 16.67B | 12.56B |
| Gross profit | -1.01%7.03B | 929.55%2.72B | -80.05%408M | 1.66B | 2.24B | 7.11B | 264M | 2.05B |
| Operating expense | 81.37%11.57B | 274.25%6.5B | -200.90%-1.57B | 4.92B | 1.72B | 6.38B | 1.74B | 1.56B |
| Operating profit | -727.07%-4.54B | -156.73%-3.78B | 304.50%1.98B | -3.26B | 521M | 724M | -1.47B | 489M |
| Net non-operating interest income (expenses) | -16.81%-132M | -96.15%-51M | -13.04%-26M | -24M | -31M | -113M | -26M | -23M |
| Non-operating interest income | 40.82%69M | 33.33%28M | 22.22%11M | --25M | --5M | --49M | --21M | --9M |
| Non-operating interest expense | 11.11%180M | 55.32%73M | 0.00%32M | --44M | --31M | --162M | --47M | --32M |
| Total other finance cost | --21M | --6M | --5M | --5M | --5M | ---- | ---- | ---- |
| Net investment income | 85.85%604M | 133.33%168M | 102.74%4M | 17M | 415M | 325M | 72M | -146M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 9,219.35%2.83B | -31M | ||||||
| Income from associates and other participating interests | -70.73%-70M | -171.43%-19M | -150.00%-25M | -17M | -9M | -41M | -7M | -10M |
| Special income (charges) | 128.63%1.63B | 198.42%5.43B | -10,942.86%-3.87B | 70M | 0 | -5.7B | -5.51B | -35M |
| Less:Other special charges | 182.54%534M | 7,360.00%373M | 331.43%151M | ---- | ---- | --189M | --5M | --35M |
| Less:Write off | -139.31%-2.17B | -205.28%-5.8B | --3.71B | ---- | ---- | --5.51B | --5.51B | --0 |
| Other non-operating income (expenses) | -16.19%88M | 8.89%49M | -105.56%-1M | 17M | 23M | 105M | 45M | 18M |
| Income before tax | 108.58%406M | 166.65%4.62B | -761.09%-1.94B | -3.2B | 919M | -4.73B | -6.93B | 293M |
| Income tax | 791.70%2.04B | 583.59%2.18B | -1,384.06%-886M | 473M | 274M | 229M | -451M | 69M |
| Net income | 67.04%-1.64B | 137.64%2.44B | -568.75%-1.05B | -3.67B | 645M | -4.96B | -6.48B | 224M |
| Net income continuous operations | 67.02%-1.64B | 137.64%2.44B | -569.20%-1.05B | ---3.67B | --645M | ---4.96B | ---6.48B | --224M |
| Noncontrolling interests | -51M | -51M | 0 | 0 | 0 | 0 | 0 | |
| Net income attributable to the company | 68.06%-1.58B | 138.43%2.49B | -568.75%-1.05B | -3.67B | 645M | -4.96B | -6.48B | 224M |
| Preferred stock dividends | ||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 68.06%-1.58B | 138.43%2.49B | -568.75%-1.05B | -3.67B | 645M | -4.96B | -6.48B | 224M |
| Gross dividend payment | ||||||||
| Basic earnings per share | 68.12%-60.96 | 138.41%95.98 | -567.67%-40.36 | -141.45 | 24.87 | -191.22 | -249.89 | 8.63 |
| Diluted earnings per share | 68.12%-60.96 | 138.26%95.6101 | -567.67%-40.36 | -141.45 | 24.87 | -191.22 | -249.89 | 8.63 |
| Dividend per share | 20.00%36 | 20.00%18 | 0 | 18 | 0 | 30 | 15 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |